āagman

Not investment advice. Data and computed figures, for information only.

ERIS Lifesciences Ltd

NSE: ERIS
₹1,148.80
−₹0.80 (−0.07%)
NSE · 15 Oct 2026, close
As of 31 Mar 2026
Market Cap
₹16,242 Cr
CMP
₹1,148.80
52-wk High / Low
₹1,740 / 1,138
P/E
24.8
P/B
4.2
Book Value
₹282.0
Div Yield
0.62%
ROCE
14.0%
ROE
18.7%
Face Value
₹1
D/E
0.60

Price−28.0% over 1Y

āagman read

Computed by āagman
Derived from 12 years and 15 quarters of filings. Not reported by the company.
As of 15 Oct 2026
Piotroski F-Score
7
/ 9
7 of 9 F-score tests passed
Graham Number
₹533
√(22.5 × EPS × book value per share)
ROIC
13.4%
vs 11.2% sector median
Cash flow to profit
0.83
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
−193
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
15.8%
ROE × earnings retention ratio
ROE stability
2.7
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.22FII −0.63DII +0.36
Latest quarter vs the previous one
Cash-accrual divergence
1.6%
of assets
Low = accruals track cash flow
Strengths
+Promoter holding rose by 1.3pp over the last year
+Piotroski F-Score of 7/9 is in the strong band (≥7)
+PE of 24.8x is below the sector median of 45.9x
Watch-outs
−Latest ROCE of 14% trails the sector median of 17%
−Price trades below its 200-day moving average (0.8x)
−Price is 34.0% below its 52-week high

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales467505486551720741727705773792807757873
Expenses297324311402470477477453496504526484577
Operating Profit170181176148250265250252277288282272296
OPM %36.4%35.8%36.2%26.9%34.7%35.8%34.4%35.7%35.8%36.4%34.9%35.9%33.9%
Other Income13415254843−1722
Interest17161833605957544950494647
Depreciation41424654768081777169707072
Profit before tax11212611677116129116129161173145159179
Net Profit9412210180909687102125134109279143
EPS (₹)6.989.077.555.226.126.736.156.898.668.827.3220.3310.28

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 12 years + TTM
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5465977508569821,0741,2121,3471,6852,0092,8943,1293,230
Expenses4274254805336377027818581,1461,3321,8762,0092,092
Operating Profit1181722693223453724314895396771,0181,1201,138
OPM %21.6%28.8%35.9%37.6%35.1%34.6%35.6%36.3%32.0%33.7%35.2%35.8%35.2%
Other Income732526311292292218−9−9
Interest00111232242685231193191
Depreciation1620232636504365117183315280281
Profit before tax109154270312317331394442405431489639657
Net Profit89135247295291297355406374397375648666
EPS (₹)6,489.459,714.1817.9521.3921.1521.8426.1629.8828.1028.8225.8444.7246.75

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital0014141414141414141414—
Reserves2662995538481,1371,2831,5631,8952,1822,5732,8413,889—
Borrowings10137717607848772,7812,4782,359—
Other Liabilities91981241701752052022333371,3661,415861—
Total Liabilities3573976921,4081,5021,5021,7852,2263,4106,7346,7477,123—
Fixed Assets72712327717618758549182,5684,3195,3065,188—
CWIP000034227222067171—
Investments1671903033653567829452037166762—
Other Assets1191361572713835446367617832,3791,3071,702—
Total Assets3573976921,4081,5021,5021,7852,2263,4106,7346,7477,123—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity90901312002352232713753782924861,065538
Cash from Investing Activity−83−92−44−184−590−5123−323−320−975−1,828−78−369
Cash from Financing Activity−20−84−24363−221−335−82−456881,380−881−314
Net Cash Flow5−24−88−360−3014538105−145

Ratios

As of 31 Mar 2026
13 periods
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %64.047.053.060.034.026.025.027.025.017.011.012.014.0
ROE %————————————18.7
EPS (₹)5,121.456,489.459,714.1817.9521.3921.1521.8426.1629.8828.1028.8225.8444.72
Book Value (₹)————————————282.0
Face Value (₹)————————————1
P/E————————————24.8
Div Yield %————————————0.62
NPM %13.916.122.531.933.428.727.329.129.722.119.512.920.8
OPM %19.022.029.036.038.035.035.036.036.032.034.035.036.0
D/E0.010.000.000.000.440.150.000.000.040.401.070.870.60
P/B————————————4.2

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+18.0%
5 years+21.0%
3 years+23.0%
TTM+10.0%
Compounded profit growth
10 years+17.0%
5 years+12.0%
3 years+19.0%
TTM+69.0%
Stock price CAGR
5 years+8.0%
3 years+10.0%
Last year−27.0%
Return on equity
10 years21.0%
5 years18.0%
3 years16.0%
Last year19.0%

Shareholding pattern

As of 31 Dec 2025
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters55.93%55.93%56.10%55.55%54.13%52.66%52.86%54.90%54.85%53.92%54.14%
FIIs8.59%8.59%8.14%10.19%12.42%13.31%14.86%14.27%8.43%6.39%5.76%
DIIs10.82%10.82%11.65%11.18%9.67%10.50%10.02%15.63%18.07%20.35%20.71%
Government———————————
Public24.66%24.66%24.11%23.08%23.78%23.52%22.27%15.20%18.64%19.33%19.39%
No. of shareholders33,12933,12929,75829,19541,47057,06145,93151,75350,08751,65650,798
Change since Jun 2023 (pp)
Promoters −1.79FIIs −2.83DIIs +9.89Public −5.27

Documents

As of 11 Oct 2026

Corporate actions

As of 29 May 2026
29 May 2026DIVIDENDInterim Dividend - Rs 7.21 Per Share—
13 Feb 2025DIVIDENDInterim Dividend - Rs 7.35 Per Share—
11 Aug 2022DIVIDENDInterim Dividend- Rs 7.35 Per Share—
5 Aug 2021DIVIDEND Interim Dividend - Rs 6.01 Per Share—
13 Aug 2020DIVIDEND Interim Dividend - Rs 5.50 Per Share—
19 Mar 2020DIVIDEND Interim Dividend - Rs 2.87 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman